Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
4.110
+0.140 (3.53%)
Nov 21, 2024, 10:43 AM EST - Market open
Inovio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 108 | 139 | 389 | 1,050 | 1,499 | 330 | |
| Market Cap Growth | 43.91% | -64.23% | -62.93% | -29.98% | 354.28% | -13.47% | |
| Enterprise Value | 31 | 2 | 140 | 688 | 1,237 | 332 | |
| Last Close Price | 3.97 | 6.12 | 18.72 | 59.88 | 106.20 | 39.60 | |
| PS Ratio | 737.78 | 167.33 | 37.93 | 591.53 | 202.30 | 80.26 | |
| PB Ratio | 1.41 | 1.19 | 1.75 | 2.63 | 3.25 | 61.06 | |
| P/TBV Ratio | 2.04 | 1.19 | 1.86 | 2.72 | 3.35 | - | |
| EV/Sales Ratio | 153.67 | 1.86 | 13.62 | 387.68 | 166.88 | 80.67 | |
| Debt / Equity Ratio | 0.17 | 0.26 | 0.14 | 0.08 | 0.08 | 18.41 | |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.03 | |
| Quick Ratio | 3.69 | 3.47 | 2.73 | 6.23 | 10.33 | 2.86 | |
| Current Ratio | 3.88 | 3.60 | 3.25 | 6.82 | 11.30 | 2.94 | |
| Return on Equity (ROE) | -106.64% | -79.55% | -89.97% | -70.55% | -71.79% | -260.83% | |
| Return on Assets (ROA) | -50.56% | -32.11% | -37.53% | -36.35% | -22.68% | -50.49% | |
| Return on Capital (ROIC) | -59.76% | -41.49% | -46.13% | -40.36% | -25.63% | -72.36% | |
| Earnings Yield | -105.23% | -97.05% | -71.90% | -28.92% | -11.10% | -36.17% | |
| FCF Yield | -103.64% | -89.56% | -55.80% | -20.66% | -11.97% | -29.95% | |
| Buyback Yield / Dilution | -16.75% | -11.51% | -14.27% | -34.62% | -57.14% | -6.68% | |
| Total Shareholder Return | -16.75% | -11.51% | -14.27% | -34.62% | -57.14% | -6.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.